Fatty Liver: all 1,462 studies
Page 6 of 15. Open to participants first (289), then studies with results posted, then the rest; newest registration first within each.
- Cholic Acid for Hepatic Steatosis in LipodystrophyCompletedNCT00457639Phase 2Results posted
- A Study of Siliphos in Adults With Non-alcoholic Steatohepatitis (NASH)CompletedNCT00443079Phase 2Results posted
- Pioglitazone to Treat Fatty Liver in People With HIV InfectionCompletedNCT00441272Phase 2Results posted
- Polyunsaturated Fatty Acids (PUFA) in Diabetic Fatty LiverCompletedNCT00323414Phase 2Results posted
- Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASHCompletedNCT00267670Phase 2/3Results posted
- Obesity and Nonalcoholic Fatty Liver DiseaseCompletedNCT00262964Not applicableResults posted
- Insulin Resistance in Non-alcoholic Fatty Liver DiseaseTerminatedNCT00252499Not applicableResults posted
- Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC)CompletedNCT00063635Phase 3Results posted
- Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)CompletedNCT00063622Phase 3Results posted
- Treating Nonalcoholic Steatohepatitis (NASH) With MetforminCompletedNCT00063232Phase 2Results posted
- Treating Nonalcoholic Steatohepatitis With PioglitazoneCompletedNCT00062764Phase 2Results posted
- Effect of Dapagliflozin on Metabolic Parameters in Patients With Non-Alcoholic Fatty Liver DiseaseCompletedNCT07881796Not applicable
- Silymarin Effects on Fatty Liver in Type 2 DiabeticsCompletedNCT07871370Not applicable
- A Prospective Study of Cold Exposure in Patients With MASHActive, not recruitingNCT07821749Not applicable
- Gdue Plus a Hypocaloric Mediterranean Diet in Adults With MASLDCompletedNCT07763626Not applicable
- GLUT-F Improves MASLD Liver FunctionCompletedNCT07724067Not applicable
- Non-Invasive Hepatic and Metabolic Index Changes After Incretin Therapy in Overweight/ObesityCompletedNCT07701005
- STANDARDIZATION OF THE PROTOCOL FOR ATTENUATION COEFFICIENT MEASUREMENTCompletedNCT07616843
- The Referral to Hepatology Can be Improved Through an Electronic Medical Record (EMR)-Based Best Practice Alert (BPA) for an Appropriate ReferralCompletedNCT07580482Not applicable
- Samsung S-Viscosity vs Canon Dispersion Slope in Steatotic Liver Disease (SAVID-SLD)Active, not recruitingNCT07530419
- The Impact of Nutrition Education and Rice Bran Supplementation on Metabolic Dysfunction-associated Steatotic Liver DiseaseCompletedNCT07524621Not applicable
- Structured Physical Activity Intervention in Patients With MASLD Receiving a Mediterranean DietCompletedNCT07478588Not applicable
- Expanded Studies on the SCAPIS Stockholm Reexamination CohortActive, not recruitingNCT07476703
- Effects of Resistance-Based Multicomponent Training Incorporating Respiratory Exercise on Diaphragm Thickness, Hepatic Attenuation, and Quality of Life in Healthy Older Men: A Randomized Controlled TrialCompletedNCT07449767Not applicable
- Single-Cell and Spatial Transcriptomics Analysis of Steatotic Donor Liver Susceptibility to Post-Transplant InjuryCompletedNCT07362745
- Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 DiabetesCompletedNCT07269197
- Ultrasound-Based Estimation of Hepatic Steatosis in Pediatric MASLDCompletedNCT07265011Not applicable
- Effect of Inspiratory Muscle Training on Diaphragm Muscle Thickness, Fatty Liver Density and Aerobic Capacity in Elderly Men: A Randomized Controlled TrialCompletedNCT07193082Not applicable
- Quantitative Ultrasound (RS85 and R20) for Liver Fat Quantification in MASLD Using MRI-PDFF as ReferenceActive, not recruitingNCT07192159Not applicable
- The Impact of Hepatic Steatosis on Survival After PancreaticoduodenectomyCompletedNCT07182136
- MHT and Liver Function in Postmenopausal WomenCompletedNCT07103603Not applicable
- Biomarkers of Steatohepatitis in Type 2 Diabetes PatientsActive, not recruitingNCT07098520
- Liver Stiffness And Steatosis Assessment In Women With Polycystic Ovary Syndrome Using FibroscanCompletedNCT07027332
- Dapagliflozin in Nonalcoholic Fatty Liver Disease (NAFLD) and Type 2 Diabetes Mellitus Patients (T2DM).Active, not recruitingNCT07020377Phase 1/2
- Mechanisms of Macrophage Polarization in HIRI in Patients With NAFLDActive, not recruitingNCT06950710
- Incidence of Liver Disease-Related Outcomes in People With HIVCompletedNCT06940375
- Ultrasound Assessment of Atherosclerotic Plaque Burden and Cardiovascular Risk: A 10-Year Prospective StudyCompletedNCT06933745
- The Ameliorative Effect of C-Kit (+) Hepatic Endothelial Cells With Mertk Deficiency on Nonalcoholic SteatohepatitisActive, not recruitingNCT06913699
- Radiological Spectrum Of Fatty Liver Correlate With High Resolution Ultrasonography Of Fibrosis And CirrhosisActive, not recruitingNCT06749522
- A Real-world Assessment in Implementation of the MASH Patient Care Pathway in Chinese Population Using the Meinian Health Check-up DatabaseCompletedNCT06741111
- : Identification of Non-alcoholic Steato-hepatitis Cases in a Sample of Type 2 Diabetes Patients, with a Disruption of the Liver Function Tests, At the Pointe-à-Pitre University HospitalCompletedNCT06738810Not applicable
- A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASLD and MASHWithdrawnNCT06692283Phase 3
- NASH Patient's Itinerary: Comparison of Strategies for Screening, Referring and Management of Diabetic PatientsCompletedNCT06688149Not applicable
- Evaluating the Efficacy and Safety of Roflumilast in Patients with NASHCompletedNCT06677788Phase 2
- Intermittent Fasting Versus Diet to Stop Hypertension on Metabolic Risk Profile in Nonalcoholic Fatty Liver PatientsCompletedNCT06666894Not applicable
- Usefulness of Ultrasound-derived Fat Fraction for Quantification of Hepatic Steatosis in Patients Suspected of MASLDActive, not recruitingNCT06662851
- New Non-invasive Biomarkers of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)CompletedNCT06647095
- Efficacy and Safety of Pemafibrate for Nonalcoholic Fatty Liver DiseaseActive, not recruitingNCT06623539Phase 2
- Tocotrienol as a Treatment for Non-alcoholic Fatty Liver DiseaseCompletedNCT06596382Not applicable
- A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASH and F2/F3 FibrosisWithdrawnNCT06594523Phase 3
- Dietary Intervention for Low Free Sugars in Children With Non-alcoholic Fatty Liver DiseaseCompletedNCT06579729Not applicable
- Liver Status and Presence of MASLD/MASH in Patients With Chronic Hepatitis BCompletedNCT06573190
- Ultrasound and Attenuation ImagingCompletedNCT06552377
- Impact of Fatty Liver on Hepatitis B TherapyActive, not recruitingNCT06535048
- Prevalence of Steatosis and Steatohepatitis in Patients Undergoing Bariatric Surgery; a Biopsy-based StudyCompletedNCT06499675
- MAFLD Fibrosis Score for Detecting Fibrotic NASH in MAFLD Egyptian PatientsCompletedNCT06492369
- Efficacy and Safety of CS0159 Combined With Semaglutide in MASH Patients With Obesity and T2DMCompletedNCT06492330Not applicable
- A Clinical Study of Ultrasound-derived Fat Fraction to Assess Metabolic Dysfunction-Associated Steatotic Liver DiseaseCompletedNCT06487325
- Metabolic Dysfunction Associated Fatty Liver Disease in Long-Term Cholecystectomy PatientsCompletedNCT06443723Not applicable
- A Clinical Trial of Chazhu Xiaozhi Decoction Against Non-alcoholic Fatty Liver DiseaseCompletedNCT06442137Phase 2
- Effect of Lifestyle Intervention on Mobilization of Fat Storage and Iron Deposition in ObesityCompletedNCT06441409Not applicable
- A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASHCompletedNCT06410924Phase 2
- Dietary Supplementation With Butyrate in Individuals With Liver Steatosis and Metabolic SyndromeCompletedNCT06398522Not applicable
- Effect of Multi-ingredient on Visceral Adiposity & Non-alcoholic Fatty Liver Disease in Postmenopausal Women With Abdominal ObesityCompletedNCT06377631Not applicable
- Ultrasound Index Fat FractionCompletedNCT06373796Not applicable
- Dose Escalation Study of Kylo-0603 in Healthy SubjectsCompletedNCT06365580Phase 1
- Implementation of the Fatty Liver Index in Primary CareCompletedNCT06363617Not applicable
- The Study of Lithogenesis Processes in Patients With Non-alcoholic Fatty Liver Disease (NAFLD)CompletedNCT06357052
- Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults MASLD Patients (DELI_MASLD Study)CompletedNCT06352697Not applicable
- Effect of Dipeptidyl Peptidase- 4 Inhibitors on Non-Alcoholic Steatohepatitis and Type 1 DiabetesCompletedNCT06348706Phase 3
- ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)CompletedNCT06342947Phase 2
- Manual Therapy in Metabolic Liver DiseaseCompletedNCT06338618Not applicable
- The Impact of Different Exercise Modes on Bile Acid Levels and Liver Function in Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT06338449Not applicable
- Metabolic Changes in Healthy Subjects with Acute Binge DrinkCompletedNCT06298318Phase 1
- Evaluation of Liver Damage in Patients With Anorexia Nervosa by Blood Biomarker AnalysisCompletedNCT06262165
- A Clinical Study of Curcuvail® in Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT06256926Phase 2
- Effect of a Food Supplementation With a Combined Food Supplement on Lipid Pattern, Indexes of Non-alcoholic Fatty Liver Disease and Systemic InflammationCompletedNCT06247137Not applicable
- Clinical Trials Using HepatoKeeper Herbal Essentials to Treat Non-alcoholic Fatty Liver Disease and Metabolic FactorsCompletedNCT06244550Not applicable
- Can Fecal Calprotectin Be Used as a Biomarker of Non-alcoholic Fatty Liver Disease In Obese Adolescents?CompletedNCT06229184Not applicable
- A Nutrigenetic Intervention in MASLDActive, not recruitingNCT06220695Not applicable
- A Phase IV Study of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty LiverCompletedNCT06202456Phase 4
- A Phase IV Study of Huazhi Rougan GranuleCompletedNCT06188611Phase 4
- A Research Study Looking at How the Compound NNC0194-0499 Works With Birth Control Pills in Women Not Able to Bear Children.CompletedNCT06188026Phase 1
- A Trial to Learn How Safe AZD9550 Monotherapy and Combined With AZD6234 is in People With or Without Type 2 Diabetes Who Are Living With Obesity and OverweightActive, not recruitingNCT06151964Phase 1/2
- A Study of BMN 255 in Participants With Non-Alcoholic Fatty Liver Disease And HyperoxaluriaWithdrawnNCT06138327Phase 1
- Proliverenol Supplementation for Non-Alcoholic Fatty Liver Disease (NAFLD)CompletedNCT06127225Phase 2
- Clinical Effects of New Approach on Patients With Non-alcoholic SteatohepatitisCompletedNCT06105060Early Phase 1
- Observational and Prospective Study of Hepatic Steatosis and Related Risk Factors Using Ultrasound and Artificial IntelligenceActive, not recruitingNCT06103175
- The Effect of Soy Isoflavones on Non-alcoholic Fatty Liver Disease and the Level of FGF-21 and Fetuin ACompletedNCT06101433Not applicable
- Fetuin-A, a Promising Serum Biomarker for Diagnosis of Non-Alcoholic Fatty Liver DiseaseCompletedNCT06097039
- A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 CirrhosisActive, not recruitingNCT06096779Phase 2
- The Potential Value and Impact of Diagnostic Biomarkers for MAFLD Using Machine Learning MethodsActive, not recruitingNCT06061640
- Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASHCompletedNCT06054815Phase 2
- The Study of Multiple Doses of CM-101 in Male and Female NAFLD (Nonalcoholic Fatty Liver Disease) and NAFLD/NASH (Nonalcoholic Steatohepatitis) SubjectsCompletedNCT06044467Phase 1
- Subcutaneous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechanisms in Healthy Male SubjectsCompletedNCT06037577Phase 1
- Effect of Vitamin A and Calcium in Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT06031532
- Pharmacoeconomic Evaluation of the Cost/effectiveness Ratio of Physical Exercise on Non-alcoholic Fatty Liver DiseaseCompletedNCT06026293
- Impact of FMT on the Phenome in Patients With NAFLD and FibrosisCompletedNCT06024681Not applicable
- Smart Watch Insights for Prevention of Exacerbations and Enhance Rehabilitation - Movement StudyActive, not recruitingNCT06011356
- Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic SteatohepatitisActive, not recruitingNCT05979779Phase 2